These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26900043)

  • 1. Cost of myopic patients with and without myopic choroidal neovascularisation.
    Ruiz-Moreno JM; Roura M;
    Arch Soc Esp Oftalmol; 2016 Jun; 91(6):265-72. PubMed ID: 26900043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prevalence of Myopic Choroidal Neovascularization in the United States: Analysis of the IRIS(®) Data Registry and NHANES.
    Willis JR; Vitale S; Morse L; Parke DW; Rich WL; Lum F; Cantrell RA
    Ophthalmology; 2016 Aug; 123(8):1771-1782. PubMed ID: 27342789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of costs associated with the management and morbidity of diabetic macular oedema and macular oedema secondary to retinal vein occlusion.
    Abraldes MJ; Pareja A; Roura M;
    Arch Soc Esp Oftalmol; 2016 Jun; 91(6):273-80. PubMed ID: 26810908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choroidal filling delay in choroidal neovascularisation due to pathological myopia.
    Wakabayashi T; Ikuno Y
    Br J Ophthalmol; 2010 May; 94(5):611-5. PubMed ID: 19846414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.
    Ikuno Y; Sayanagi K; Soga K; Sawa M; Tsujikawa M; Gomi F; Tano Y
    Am J Ophthalmol; 2009 Jan; 147(1):94-100.e1. PubMed ID: 18774550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation.
    Costagliola C; Semeraro F; dell'Omo R; Romano MR; Russo A; Aceto F; Mastropasqua R; Porcellini A
    Br J Ophthalmol; 2015 Jul; 99(7):1004-8. PubMed ID: 25770144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of visual prognoses between natural course of simple hemorrhage and choroidal neovascularization treated with intravitreal bevacizumab in highly myopic eyes: a 1-year follow-up.
    Goto S; Sayanagi K; Ikuno Y; Jo Y; Gomi F; Nishida K
    Retina; 2015 Mar; 35(3):429-34. PubMed ID: 25166271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.
    Sakaguchi H; Ikuno Y; Gomi F; Kamei M; Sawa M; Tsujikawa M; Oshima Y; Kusaka S; Tano Y
    Br J Ophthalmol; 2007 Feb; 91(2):161-5. PubMed ID: 16914470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of myopic choroidal neovascularisation treated with combined ranibizumab and dexamethasone characterised by multi-modal imaging.
    Tan AC; Teo K; Guan OS; Koh A
    Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):1881-1888. PubMed ID: 26968717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lacquer crack formation and choroidal neovascularization in pathologic myopia.
    Ikuno Y; Sayanagi K; Soga K; Sawa M; Gomi F; Tsujikawa M; Tano Y
    Retina; 2008 Oct; 28(8):1124-31. PubMed ID: 18779719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of a deep convolutional neural network in the detection of myopic macular diseases using swept-source optical coherence tomography.
    Sogawa T; Tabuchi H; Nagasato D; Masumoto H; Ikuno Y; Ohsugi H; Ishitobi N; Mitamura Y
    PLoS One; 2020; 15(4):e0227240. PubMed ID: 32298265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of inflammatory cytokines with choroidal neovascularization in highly myopic eyes.
    Yamamoto Y; Miyazaki D; Sasaki S; Miyake K; Kaneda S; Ikeda Y; Baba T; Yamasaki A; Noguchi Y; Inoue Y
    Retina; 2015 Feb; 35(2):344-50. PubMed ID: 25289657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consecutive case series with long-term follow-up of full macular translocation for myopic choroidal neovascularisation.
    Sakimoto S; Sakaguchi H; Ohji M; Gomi F; Ikuno Y; Fujikado T; Kamei M; Nishida K
    Br J Ophthalmol; 2014 Sep; 98(9):1221-5. PubMed ID: 24692747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs associated with workdays lost and utilization of health care resources because of asthma in daily clinical practice in Spain.
    Ojeda P; Sanz de Burgoa V;
    J Investig Allergol Clin Immunol; 2013; 23(4):234-41. PubMed ID: 23964552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The social cost of depression in the city of Sabadell (Barcelona, Spain) (2007-2008)].
    Pamias Massana M; Crespo Palomo C; Gisbert Gelonch R; Palao Vidal DJ
    Gac Sanit; 2012; 26(2):153-8. PubMed ID: 22055213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central retinal sensitivity after intravitreal injection of bevacizumab for myopic choroidal neovascularization.
    Yodoi Y; Tsujikawa A; Nakanishi H; Otani A; Tamura H; Ojima Y; Hayashi H; Yoshimura N
    Am J Ophthalmol; 2009 May; 147(5):816-24, 824.e1. PubMed ID: 19211092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Ng DS; Kwok AK; Tong JM; Chan CW; Li WW
    Retina; 2015 Dec; 35(12):2457-68. PubMed ID: 26035400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral bisphosphonates on myopic choroidal neovascularisation over 2 years of follow-up: comparison with anti-VEGF therapy and photodynamic therapy. A pilot study.
    Miki A; Honda S; Nagai T; Tsukahara Y; Negi A
    Br J Ophthalmol; 2013 Jun; 97(6):770-4. PubMed ID: 23603482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study.
    Amoaku WM; Gale RP; Lotery AJ; Menon G; Sivaprasad S; Petrillo J; Quinn J
    PLoS One; 2015; 10(6):e0128403. PubMed ID: 26039355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marginal crack after intravitreal bevacizumab for myopic choroidal neovascularization.
    Sayanagi K; Ikuno Y; Soga K; Wakabayashi T; Tano Y
    Acta Ophthalmol; 2009 Jun; 87(4):460-3. PubMed ID: 18479492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.